The Global Microarrays Market is expected to grow at a CAGR of 7.24% as the demand for drug discovery, disease diagnostics, and precision medicine continues to accelerate.Austin, Texas, Jan. 26, 2026 ...
Researchers at Nuclera completed the first Asian installations of its eProtein Discovery System at National Taiwan University ...
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $128.8, ...
We have developed a procedure of covalently attaching nucleic acids to 1"×3" glass microscope slides. When we calculate the degree of target wash-off during hybridisation and subsequent washes (using ...
Researchers developed a CRISPR and single-molecule microarray test that quantifies Candida auris and detects antifungal resistance in under 40 minutes. The assay provides rapid, precise results from ...
New “AI GYM for Science” dramatically boosts the biological and chemical intelligence of any causal or frontier LLM, ...
SHERLOCK, a rapid CRISPR-based diagnostic, detects Candida auris and antifungal resistance mutations in patient samples in under an hour.
Nanjing Drum Tower Hospital Center of Molecular Diagnostic and Therapy, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, NJU Advanced Institute of Life Sciences, State Key ...
JPT is a key player in the world of peptides. They create special tools like peptide microarrays that help map out immune responses. They also offer services that speed up the creation of new ...
Nuclera, the biotechnology company providing rapid access to functional proteins for drug discovery, has completed its first installations in Asia. Systems are now operational at the National ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results